Dermatology Flashcards
Canine atopic dermatitis (CAD)
Genetically predisposed inflammatory and pruritis skin Dz
Ass with IgE
Common allergens
-dust mites, pollen, mould spores, food
Dx Env/ food induced
No detectable allergens
-Atopic like dermatitis
CAD pathogenesis
Cutaneous inflammation and pruritus
Defective skin barrier function
Microbial colonisation
- more staph
Other flares
Type 1 hypersensitivity
IgE bound to Mast cells
Allergen bound by IgE causes mast cell degranulation
This causes inflammation
-histamine, PG, IL
T IV hypersensitivity
Allergen peptides presented to T cells by langerhan cells
Induce clonal expansion
Tcells make pro-inflammatory cytokines (IL4, 13, 31)
B cells produce IgE
CAD Dx
Compatible hx
CS
Exclusion of Ddx
No pathognomonic signs
CAD CS
Pruritus
1° lesion- erythema and papules
2° lesion- otitis, lesions due to pruritus, alopecia, saliva staining, lichenification
Favrot criteria
Onset of CS <3y/o
Dog outdoors alot of the time
Responds to glucocorticoids
Pruritus sine materia
Affects front feet/ pinna
Non affected ear margins
non affected dorso lumbar area
Pruritus Ddx
Ectoparasites-
-Sarcoptes, cheyletiellosis, fleas
Allergic skin Dz-
-CAD, contact dermatitis
Microbial infection-
-Bac pyoderma, Malasezzia
Other
-Pemiphigus foliaceus, epithuliotropic lymphoma
Food allergy terminology
AD- Atopic dermatitis (sensu strictu)
NFIAD- Non-food induced AD
>+ve Ag specific IgE tests (AD)
>-ve Ag specific IgE tests (Atopic like dermatitis)
FIAD- Food induced AD
> Immune mediated food allergy
>Non-immune medicated food intolerance
FIAD
Maltese-beagle X, Westie, Boxer
Dx- elimination diet, no seasoanlity
-IgE X reactions
Hydrolysed protein diets-
-Assumes T I Hyper sensitivity
Food trials
Minimum 6 weeks
Challenge in face of improvement
Use diary
Steroids initially to lower 2° inflammation
AD summary
Compatible history and clinical signs
Favrot’s criteria (use as a check)
Exclude all differential diagnoses
-Ectoparasites, other allergies (food, fleas) and secondary
- infections (pyoderma, yeast)
Serology or intradermal tests if ASIT an option for management
Tx of CAD
Improve skin barrier
Allergen avoidance and AIT
Control inflammation and pruritus
Control flare factors
Improve skin barrier function
Reduce transepidermal water loss
Reduce exposure to environmental allergens and irritants
Reduce microbial colonisation and inflammation
Tx-
Non irritating shampoos
Topical moistures and emollients
Supplementation with oral/ topical EFA (essential fatty acids)
Allergen avoidance and allergen immunotherapy
Preventative therapy
Desensitisation to environmental allergens via induction of tolerant state in peripheral T cells
Allergens- Dust mites, mould spores, pollen (seasonal)
AIT-
Administration of gradually increasing quantity of allergen
Ameliorate CS
Allergen intradermal testing to ID specific allergens
Trial over 12m